Significant main effects of treatment group (prior to BenjaminiHochberg correction since none were significant after correction, although the necessity of correction for multiple comparisons in exploratory analyses remains unresolved 49 ) were observed for the unclassified group and ten classified genera, namely, Acetatifactor , Akkermansia , Erysipelatoclostridium , [ Eubacterium ] coprostanoligenes group , Family XIII UCG-001 , Lactobacillus , Parasutterella , Ruminiclostridium 6 , Ruminococcaceae UCG-004 , and Ruminococcaceae UCG-009
May Reduce Depression Risk Studies into depression have suggested that low B12 can be a cause of a depressed mood
Protocol 3: fat loss and body recomposition (2-3 peptides) Goal: Maximize fat loss while preserving or building lean mass Peptides: Semaglutide : Start 0.25mg weekly, titrate to 1-2.4mg weekly over 8-16 weeks BPC-157 : 250mcg twice daily (protects gut health during GLP-1 use) Optional third: Ipamorelin 100mcg twice daily (supports lean mass preservation) Why this works: Semaglutide provides powerful appetite suppression and improved insulin sensitivity for fat loss
AOD-9604 isn't available as a standard commercial medication
Machiraju, P., Wang, X., Sabouny, R., Huang, J., Zhao, T., Iqbal, F., King, M., Prasher, D., Lodha, A., Jimenez-Tellez, N., Ravandi, A., Argiropoulos, B., Sinasac, D., Khan, A., Shutt, T